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Chronic kidney disease (CKD) and cardiovascular disease (CVD) 
share common risk factors such as smoking, hypertension, diabetes, 
obesity and hyperlipidaemia, and both have links to poverty and 
malnutrition. The burden of these chronic diseases is increasing.1 
CVD comprised 30% of all deaths in the world in 1998, most (78%) 
occurring  in low- and middle-income countries.2 The global burden 
of diabetes and CVD is set to rise by around 50% and 150% in the 
developed and the developing worlds, respectively. It is estimated 
that by 2020,  in Africa alone, nearly 22.3 million people will have 
diabetes, resulting in concomitant increases in the prevalence of 
CKD and end-stage renal disease (ESRD).3 This means that more 
patients will die of stroke, heart failure and kidney failure, with the 
greatest impact in developing world regions such as South Africa.
In resource-challenged health systems the focus has to move 
from expensive ‘end-of-the-road’ interventions such as dialysis 
and transplantation to early intervention and primary prevention 
strategies. We have to move towards involving and integrating care 
between specialists, primary care clinicians and the community to 
tackle this massive challenge.
As mentioned above, because both CVD and CKD share common 
risk factors, we can therefore employ common prevention strategies. 
These risk factors remain the leading causes of death worldwide 
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in developed and developing countries 
(Fig. 1).2 The early diagnosis and treatment 
of chronic diseases produces striking 
reductions in morbidity and mortality, as 
can be seen from the evidence produced 
by Wendy Hoy in the Australian integrated 
Chronic Disease Outreach Program (Fig. 
2).4 Unfortunately there is little information 
to inform planning of systematic chronic 
disease management programmes in 
South Africa. In chronic illness treatment 
programmes it is noted that most affected 
people have more than one morbidity, 
justifying integrated, rather than disease-
specific, programmes (Fig. 3).5 
In addition to the large burden of non-
communicable diseases (NCDs) in deve-
loping countries, there is the problem of 
infectious diseases having an impact on 
the increased prevalence of CKD. 
Seriousness of the problem 
in South Africa 
NCDs account for 37% of all deaths in 
South Africa, and HIV for a further 30%.6 
The HIV/AIDS epidemic continues to 
grow at a rapid rate.  UNAIDS estimated 
that in 2000, 19.9% of adults were infected. 
Projections differ somewhat, but suggest 
that between 2000 and 2010  from  4 to 
7 million people will die of AIDS.7  The 
estimated burden of renal deaths in HIV 
is unknown. HIV,  when treated with 
antiretroviral agents, can behave like a 
chronic disease. The combined effect of 
diseases such as diabetes, hypertension and 
HIV will have a large impact on CKD.  
The Kidney Disease Outcomes Quality 
Initiative (KDOQI) guidelines have 
significantly improved our focus for 
detecting, following and managing patients 
with CKD.8  No reliable statistics for CKD 
exist for any African country, including 
South Africa. In a chronic disease 
outreach programme (CDOP) running 
in Soweto it was found that among 619 
patients being managed at primary care 
clinics with high-risk diabetes (diabetes 
with hypertension or proteinuria) and 
uncontrolled hypertension, 12% had 
advanced kidney disease, i.e. a glomerular 
filtration rate (GFR) < 60 ml/min, and 
of these some (2%) required immediate 
dialysis (Fig. 4).9  Considering that only a 
small number of the 40 000 patients being 
treated at these clinics were screened, 
the problem is larger than we would like 
to think.10 We need to understand and 
grasp the burden of risk factors in South 
Africa so that we can recognise the need 
for a comprehensive early detection and 
prevention strategy.




In South Africa the CVD and CKD burden, 
both sharing the same disease risk factors 
of hypertension and diabetes, were eval-
uated to some extent  in the Demographic 
and Health Survey in 1998. This national 
cross-sectional survey is probably the 
most geographically representative survey 
to date.6 In a random sample of 13 802 
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Fig. 1. World deaths in 2000 attributable to selected leading risk factors,
World Health Report 2002.
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Fig. 2. Patients starting dialysis and natural deaths in adults (≥ 18 years)
being managed on the Australian integrated Chronic Disease Outreach
Program.
#Annual rolling average to mid-2003.
All-cause morbidity; main factors affecting all-cause mortality were strokes, heart
failure and kidney failure.
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Fig. 2. Patients starting dialysis and natural 
deaths in adults (≥ 18 years) being managed 
on the Australian integrated Chronic Disease 
Outreach Program.
†
Annual rolling average to mid-2003
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Fig. 3. Overlapping morbidities of chronic disease among screened adults














Fig. 4. Patients screened for chronic kidney disease in a chronic disease
outreach programme in Soweto. (GFR calculated using the modified
modification of diet in renal disease (MDRD) formula and required patients,
gender, race and serum creatinine ( mol/l).)
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people the prevalence and treatment 
status of hypertension in South Africans 
≥ 15 years old were evaluated. The cut-off 
blood pressure levels used for analysis were 
≥ 160/95 mmHg, but later analysis by Steyn 
et al. included the more appropriate cut-
off of ≥ 140/90 mmHg.6 The prevalence of 
hypertension in the SA survey was found 
to be 21% in both men and women, overall 
and the level of control was worse in men 
compared with women (11% and 18% 
respectively). This was worse than the 
level of control in the NHANES III survey, 
where there was only 27% hypertension 
control overall (Table I).  Just over 50% 
were aware of their diagnosis and less than 
50% were being treated. Thus, hypertension 
remains poorly diagnosed and managed in 
South Africa. In an unpublished review of 
chronic disease control in Soweto clinics, 
the control of hypertension and diabetes 
was dismal.11 Only 8.4% of patients seen 
at the clinics had moderately acceptable 
control of blood pressure (< 140/90 
mmHg), which was similar for diabetes 
control (< 7% having blood glucose 
< 8 mmol/l).  
Diabetes is conservatively estimated 
to occur in 4 million South Africans.6 
In South Africa diabetic nephropathy 
remains a very important risk factor for 
CKD and CVD.  Incipient nephropathy 
is reported in 32 - 57% of patients, with 
a mean known duration of diabetes of 5 -
10 years in a hospital-based study.12 Overt 
proteinuria was reported in 5 - 28% and it 
increased with duration of diabetes.  
The South African Demographic and 
Health Survey further indicated that 4 
million South Africans are suspected of 
having hyperlipidaemia.  It also showed 
that 29% and 9% of females and males, 
respectively, were obese (BMI > 30 
kg/m2), and 55% and 29%, respectively, 
were overweight (BMI > 24 kg /m2). In the 
pilot Soweto CDOP the presence of major 
risk factors was extremely prominent 
and over 60% of patients  were obese.6 
In the same population group 35% had 
evidence of proteinuria. In a recent survey 
of 551  people in the ‘normal population’ 
in Soweto, as part of the Heart Awareness 
Day programme, similar risk factor profiles 
were observed: 43% with a BMI of > 30 
kg/m2, 8% with diabetes, 5% with 
cholesterol levels > 5.5 mmol/l, 29% 
with 1+ or more microalbuminuria on 
single testing, 16% smokers and 26% 
with hypertension.  It was also noted that 
as many as 8% of people screened were 
unaware of their hypertension status 
(Fig. 5).13
Various forms of kidney disorders occur 
in patients who are HIV positive.  Han 
et al.,14 at a single centre in KwaZulu-Natal, 
screened 615 asymptomatic outpatients 
who had no evidence or symptoms of 
CKD or renal risk factors other than 
HIV.  Of these patients 7.8% were found 
to have persistent microalbuminuria: 
all had had renal biopsies and 85% had 
HIV-associated nephropathy (HIVAN), 
with most patients having a CD4 count 
< 250 x 106/l. Considering that 4 - 7 million 
South Africans have HIV, this is potentially 
an additional large CKD burden. 
These studies highlight the existence of co-
existing risk factors and co-morbidities in 
chronic disease and ‘normal’ populations. 
It also demonstrates the poor awareness 
and management of these risk factors and 
chronic diseases in patients diagnosed 
with a problem.
Early de tec tion and 
prevention: tack ling the 
problems
A clear, simple and integrated approach to 
risk factor and chronic disease manage-
ment needs to be adopted. Lifestyle 
measures remain the key to the epidemic 
of NCDs and HIV in the developing 
world. Public education and commitment 
to a healthy lifestyle, e.g. no smoking, low-
salt diets, prudent eating plans, exercise 
and reducing high-risk sexual behaviour, 
need to be emphasised. An integrated 
plan, also focusing on high-risk groups, 
with effective management at all levels of 
CVD and CKD remains essential.
The WHO recognises the difficulty in 
achieving ideal circumstances and therefore 
advises those in the developing world to 
follow a more practical approach, which 
can still be further modified according to 
one’s capacity. The WHO outlines methods 
for achieving this approach by advising the 
development of a hierarchical framework 
to unify surveillance and prevention 
programme activities, recognising that 
these should be flexible across a range of 
risks, conditions, ages and areas.15  Standard 
methods and tools are adaptable to local 
settings. Starting with common core 
methods, tools and treatments optional 
extras are then developed if possible. If, 
for example, the only method available is 
lifestyle modification then this is where 
the programme focus should begin. The 
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Table I. Blood pressure prevalence, awareness, treatment and control in South 
African population-based survey (adults ≥ 15 years of age)6
 
    Men(%)                Women(%)  
  BP ≥  BP≥  BP≥  BP≥  
  140/90  160/95  140/90  160/95  
  mmHg  mmHg  mmHg  mmHg
Prevalence 20.9  11  21.2  14  
Aware  26  41  51  67  
Treated  21  39  36  55  





Fig. 5. Patients screened in Heart Awareness Day programmes in Soweto.
(Normal = blood pressure found to be < 140/90 mmHg; known hypertension (HT)
= person being treated or aware of HT diagnosis; new HT = person unaware that
he/she had high blood pressure.)
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Fig. 6. The WHO STEPS Framework - integrating NCD surveillance into
research on high blood pressure.
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Fig. 7. Potential approaches for early screening for detection and
prevention of CKD and CVD risk factors.
1. Community 2. Health System



















Improved Functional and Clinical Outcomes
Fig. 8. Wagner Chronic Illness Care Model – recognises the complexity of
chronic disease care and that changes in the health system, community
resources and policies will improve chronic illness care.
Fig. 7. Potential approaches for early screen-
i g for detection and prevention of CKD and 
CVD risk factors.
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primary aim is to develop basic sentinel 
surveillance and treatment sites, and 
then to add on to existing systems when 
resources allow (Fig. 6).
Implementing 
programmes for chronic 
disease screening and 
management
It would be ideal to do large population-
based screening studies before embarking 
on a prevention strategy, but this is not 
feasible or cost effective in a developing 
country such as South Africa. A more cost-
effective approach must be established 
taking into account that the majority of 
people will need to be managed by the 
primary health care sector. The approach 
in South Africa and other countries has 
been to focus on high-risk population 
groups (Fig. 7).
Integrated mode l for 
managing chronic 
illnesses 
The CDOP was initiated in 1999 in 
Soweto – a city of predominantly indi-
genous South African people. It is a melting 
pot of ‘transitional’ people, moving from a 
culturally healthy traditional lifestyle to 
a predominantly unhealthy westernised 
urban lifestyle.  This community is also 
at high risk of chronic diseases, including 
HIV.16 Against a known background of 
poor blood pressure and glucose control 
the programme was implemented in 20 
primary care clinics in Soweto and nearby 
regional clinics. It is developed around 
the Wagner Chronic Illness Care Model 
that focuses on creating a prepared and 
proactive health team and an informed 
patient (Fig. 8).17 The WHO has adopted 
this integrated model of managing chronic 
illnesses such as hypertension, diabetes 
and HIV. The CDOP is an integrated 
chronic illness programme based on 
an understanding that adequate blood 
pressure control, diabetic control and 
risk factor control will confer a specific 
effect (advantage) in preventing, reversing 
or retarding diabetes, hypertension and 
proteinuria as well as established CKD and 
CVD.16 
It does this by focusing on critical 
components of disease and treating 
people, as well as tracking and analysing 
clinical outcomes. These components 
include simplifying the targets for blood 
pressure, glucose and proteinuria control, 
providing ongoing patient education, 
management support for health workers, 
and regularly evaluating the achievement 
of clinical outcomes. It should have a 
qualitative component that serves to 
assess the health delivery system, health 
workers and patient compliance and 
satisfaction, ensuring that chronic illness 
care is dynamic,  achieving its targets,  and 
meeting the needs of the population at risk. 
The focus in developing countries is also on 
high-risk groups, recognising the resource 
capabilities of these health services. 
In Soweto the CDOP,  an integrated care 
programme that has been running since 
1999, has progressed from a pilot phase 
(1999 - 2001) to a paper-based system 
(2003 - 2005).  Most recently CDOP has 
developed and started a web-based system 
of patient management, including up and 
down referral to improve efficiency and 
communication. The programme focuses 
on both kidney and cardiovascular risk 
factors and on achieving quantitative 
clinical targets, e.g. HbA1c and random 
glucose control.  The programme provided 
important baseline surveillance data of the 
community and proved very popular with 
primary health clinicians and managers, 
providing ongoing decision support 
and health information.  Reduction in 
end points (kidney failure, heart attack, 
strokes) and qualitative evaluation of the 
programme remain targets in the ongoing 
phases, although control of clinical targets 
has been achieved.  A decrease in blood 
pressure was observed in programme 
participants, which, if sustained, would 
offer both cardiovascular and renal 
benefits. The blood glucose levels at 
baseline were all high (95% > 12 mmol/l) 
and by 6 months nearly 75% had glucose 
levels ≤ 10 mmol/l. This was a significant 
movement relative to baseline but above 
desired targets of control, i.e. < 8 mmol/l. 
It reflected difficulties to achieve control 
even with active intervention. Changing 
health workers’ health practices, and 
people’s eating habits and lifestyle, is more 
difficult than just adding a drug, as is the 
case for hypertension. Similar trends for 
risk factor control have continued into the 
paper-based and web-based phases.18
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Fig. 9. A CDOP ‘Functioning Unit’ indicating the structure of the CDOP
Early Detection and Prevention Programme.
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Integrated health care 
model and structure
A tertiary hospital (Chris Hani Baragwanath) 
served as the focal point for decision 
support for primary care clinicians,  data 
collection (surveillance), data analysis and 
overall management of the programme 
(Fig. 9). The CDOP ‘Functioning unit’ was 
established to fit into the cluster of primary, 
secondary and tertiary hospitals in a region. 
This model is the basis for public health 
primary  and tertiary care communication 
as well as up and down referral of patients.
It is also a model suitable for private health 
care. It recognises that a single academic 
or tertiary hospital takes referrals from a 
region of health services including primary 
health clinicians (family practitioners) and 
smaller hospitals, e.g. regional hospitals. 
The key component of this model is firstly 
recognising which patients can be managed 
by a primary care centre, which patients 
need advice only (decision support) and 
which patients need referral (specialist 
management). In developing this model it 
is critical to understand what primary care 
clinicians and existing resources can cope 
with, and when they should refer patients 
for specialised care. The ‘red’, ‘orange’ and 
‘green’ traffic light approach was used to 
open doors or keep them closed for referral. 
The programme defined red to mean that 
the door for referral was open, e.g. GFR < 
60 ml/min and multiple risk factors.  Orange 
was used to indicate that the health worker 
should continue with caution and should 
observe the clinical problem until a further 
review in 6 -12 months, e.g. HbA
1c
 not 
at target < 7%. A specialist still provided 
regular decision support if required. When a 
green light was given then the primary care 
clinician was permitted to continue with 
management and would screen again at a 
later date. 
This restructuring of the health system, as 
per the Wagner model, allowed patients 
to be referred directly to a specialist clinic 
without being referred via a casualty 
department. Patients would then arrive at 
the specialist centre with the appropriate 
investigations completed and a history of 
his/her disease and progress already known. 
This resulted in improved efficiency in the 
management of the patient at the time of 
consultation. Once patients were stabilised 
they could be referred back to their primary 
clinic for ongoing care, unless their disease 
was too advanced, e.g. GFR < 30 ml/min. 
Such a patient would remain at the tertiary 
centre’s kidney disease remission and 
regression clinic and be prepared for dialysis 
or transplantation if necessary at a later 
stage. This process has been developed by 
nephrologists and takes into account factors 
causing both the initiation and progression 
of CKD and is a key in its management as a 
public health problem.19 




It is definitely possible to establish a 
chronic disease outreach programme in 
the developing world. There are some 
additional, important fundamental issues 
to consider and remember when developing 
and implementing programmes for 
preventing kidney disease.  It is important 
to develop strong links with experts and 
try to receive assistance when needed from 
local or international organisations that 
have had experience in prevention and early 
detection programmes. One has to ensure 
that when managing chronic diseases in less 
developed countries, the establishment of 
an informed and proactive health team and 
strong patient and community partnerships 
is a priority. Establishing links and 
improved communication between primary, 
secondary and tertiary services involves 
ongoing joint planning and commitment. 
These components remain as important as 
adequate funding.  One has to focus not 
only on the technical aspects but also on 
supporting or caring for staff.  It is critical to 
recognise that good-quality chronic disease 
management is best care delivered by a well- 
functioning team, and does not rest only 
on the specialist or primary care clinician 
alone. Ultimately one has to have the long-
term commitment and stamina to build a 
chronic disease programme. 
Conclusions – integrated 
approach to CKD 
management
Novel methods of tackling the increased 
burden of CKD and CVD have to be 
established in the developing world if we are 
to tackle the daunting future burden facing 
our communities. We have to move from 
the ‘find and fix it’ model of treating diseases 
to a more proactive, integrated approach of 
tackling common risk factors, early detection 
of high-risk patients and then joint specialist 
and primary health care management. In 
treating the common diseases and risk 
factors such as diabetes, hypertension, 
obesity, hyperlipidaemia and HIV we will 
ultimately be reducing the burden of CKD 
and CVD in our communities. The examples 
and lessons learned in South Africa could 
serve as a template as well as a stepping stone 
for other developing world and African 
communities. 
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CKD –  ter t iar y  and primar y health c are
In a nutshell 
•    There is a close relationship between chronic kidney disease (CKD) and cardiovascular disease (CVD) and both are rising worldwide.
•    In resource-challenged health systems we have to place a large emphasis on early detection and comprehensive high-quality management 
of chronic illnesses.
•    Most affected people have more than one chronic illness, e.g. hypertension and obesity, justifying integrated rather than disease- specific 
programmes.
•    Non-communicable diseases (NCDs) account for most deaths in South Africa and, together with HIV (a chronic illness), make chronic 
illnesses a major burden of illness and death in this country.
•    Research and subsequent clinical guidelines have significantly improved our focus for detecting, following and managing patients with 
CKD and CVD.
•    A clear, simple and integrated approach to risk factor and chronic disease management needs to be adopted, using chronic illness manage-
ment models such as the Wagner Chronic Illness Care Model.
•    Primary health care clinicians and specialists have to work together as a team to ensure that patients with a significant disease burden are 
detected and treated.
•    An integrated model requires an understanding of existing resources capacity, when patients should be managed in primary care and when 
they should be referred for specialised care.
Single suture
Antibodies fight malaria
Antibodies taken from Gambian people who are immune to malaria could be used to protect others from infection. Researchers already 
know that certain people are resistant to malaria because of a potent antibody that they have to a protein on the parasite’s surface called 
merozoite-surface protein (MSP-1). But attempts to make vaccines using these antibodies have failed because they are difficult to test 
on animals. 
Now, Richard Pleass and others of the University of Nottingham, UK, have developed a system for testing the antibodies in mice and 
used it to extract and refine antibodies taken from 10 Gambian individuals who are immune to malaria. They did this by genetically 
modifying Plasmodium berghei, which infects mice, so that it makes MSP-1, which is recognised by the human immune system. Tests in 
culture had already shown that the antibodies killed the human malaria parasite but, by giving the genetically modified malaria parasite 
to mice, the team showed that the antibodies would protect the engineered animals as well. Mice without the human antibodies died.
New Scientist, 26 May 2007.
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